Enantioselective Access to Key Intermediates for Salvinorin A and Analogues
Don Antoine Lanfranchi, Christophe Bour, Gilles Hanquet
European journal of organic chemistry May 1, 2011 DOI: 10.1002/ejoc.201100207 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Salvia divinorum |
Abstract
Abstract: Access to enantiopure synthetic platforms that can generate key intermediates for salvinorin A analogues through diastereoselective Diels–Alder cycloaddition between an enantiopure sulfinylquinone and semicyclic dienes is described.
Citations in the library
Cited by 3
- Total Synthesis of the Neoclerodane Diterpene Salvinorin A via an Intramolecular Diels–Alder Strategy Organic Letters May 22, 2018
- Chemical syntheses of the salvinorin chemotype of KOR agonist. Natural Product Reports November 18, 2020
- A Protecting-Group-Free Synthesis of (-)-Salvinorin A. Chemistry - A European Journal May 20, 2021
Cites 15
- Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences September 3, 2002
- Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. Journal of Pharmacology and Experimental Therapeutics September 1, 1988
- Salvinorin A: from natural product to human therapeutics. Molecular interventions October 1, 2006
- Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptors. Biochemistry June 21, 2005
- DOM (STP), a New Hallucinogenic Drug, and DOET: Effects in Normal Subjects American Journal of Psychiatry September 1, 1968
and 10 more in the library